Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatocyte transplantation.

Ira J Fox1, Jayanta Roy Chowdhury

  • 1Department of Surgery, University of Nebraska Medical Center, Omaha, NE, USA. ifox@surgery.unmc.edu

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
|February 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PNPLA3-I148M genetic variant rewires lipid metabolism to drive programmed cell death in human hepatocytes.

JCI insight·2025
Same author

Human-induced pluripotent stem cell-based hepatic modeling of lipid metabolism-associated TM6SF2-E167K variant.

Hepatology (Baltimore, Md.)·2025
Same author

Human-induced pluripotent stem cell-based hepatic modeling of lipid metabolism-associated TM6SF2-E167K variant.

Hepatology (Baltimore, Md.)·2024
Same author

Variants in autophagy genes MTMR12 and FAM134A are putative modifiers of the hepatic phenotype in α1-antitrypsin deficiency.

Hepatology (Baltimore, Md.)·2024
Same author

Human Induced Pluripotent Stem Cell based Hepatic-Modeling of Lipid metabolism associated TM6SF2 E167K variant.

bioRxiv : the preprint server for biology·2024
Same author

Mechanism and Effect of HNF4α Decrease in a Rat Model of Cirrhosis and Liver Failure.

Cellular and molecular gastroenterology and hepatology·2023
Same journal

Human Biopsy-Defined IRI-Selective Reperfusion Signature Prioritizes Reperfusion-Timed MEK Inhibition After DCD Liver Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same journal

OPERATIONAL TOLERANCE FOLLOWING INTESTINAL TRANSPLANTATION: A CASE REPORT WITH COMPREHENSIVE IMMUNE FOLLOW-UP FROM TRANSPLANT DAY TO THREE YEARS POST-IMMUNOSUPPRESSION WITHDRAWAL.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same journal

Can Urinary Single-Cell Transcriptomics Reveal New Dimensions of Allograft Biology?

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same journal

Tolerance meets regenerative medicine: A new route to donor-specific allograft acceptance?

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same journal

Comment on "Living donor liver transplant is associated with lower hospitalization costs than deceased donor liver transplant: a multicenter cohort study of young children transplanted for biliary atresia".

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same journal

Paclitaxel-Coated Balloon Therapy for Refractory Ureteral Stenosis in a Kidney Transplant Recipient.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
See all related articles

Hepatocyte transplantation shows promise for liver disease but faces challenges in clinical application. Improving cell integration, survival, and donor availability is crucial for successful therapeutic outcomes.

Area of Science:

  • Hepatology
  • Transplantation Biology
  • Regenerative Medicine

Background:

  • Hepatocyte transplantation is explored as an alternative to organ transplantation for severe liver disease.
  • Experimental successes have spurred clinical trials, but robust evidence of transplanted cell function is limited.
  • A notable case in Crigler-Najjar syndrome type I showed insufficient enzyme activity for sustained benefit.

Purpose of the Study:

  • To re-examine animal research to establish a roadmap for improving clinical hepatocyte transplantation outcomes.
  • To identify factors influencing hepatocyte integration and survival in recipient livers and spleens.
  • To address challenges in assessing graft function, detecting rejection, and ensuring donor cell availability.

Main Methods:

  • Review and analysis of existing animal research on hepatocyte transplantation.

Related Experiment Videos

  • Evaluation of methods for assessing transplanted hepatocyte function and integration.
  • Exploration of strategies to overcome barriers to successful clinical application.

    • Main Results:

    • Limited clinical success highlights the need for better understanding of hepatocyte engraftment and survival.
    • Definitive histological evidence of function and timely detection of rejection remain challenging.
    • Donor availability is a critical limitation, necessitating exploration of alternative cell sources.

    Conclusions:

    • Further research into hepatocyte integration and survival factors is essential for clinical advancement.
    • Developing reliable methods for assessing graft function and rejection is a priority.
    • Alternative cell sources, including stem cells and xenogeneic hepatocytes, warrant investigation to address donor limitations.